Reaction
Cd4 Lymphocytes Increased reporting signals
As of the last recalculation, Cd4 Lymphocytes Increased appears in 233 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is EFAVIRENZ (PRR 156.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Efavirenz | 18 | 156.2 | 156.5 |
| Lamivudine | 34 | 114.9 | 115.1 |
| Lamivudine Oral | 28 | 112.2 | 112.4 |
| Zidovudine | 15 | 107.0 | 107.2 |
| Abacavir Sulfate | 9 | 85.8 | 85.9 |
| Nevirapine | 8 | 82.0 | 82.1 |
| Imatinib | 14 | 75.4 | 75.4 |
| Lopinavir And Ritonavir | 10 | 68.8 | 68.9 |
| Cabotegravir | 6 | 68.1 | 68.2 |
| Ganciclovir | 7 | 63.0 | 63.0 |
| Ganciclovir Sodium | 7 | 60.9 | 60.9 |
| Imatinib Mesylate | 14 | 47.6 | 47.7 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 9 | 46.1 | 46.1 |
| Dolutegravir Sodium | 4 | 40.3 | 40.3 |
| Dalfampridine | 22 | 30.1 | 30.2 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 3 | 27.0 | 27.0 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 23.9 | 23.9 |